Schedule 13G ownership disclosure
CATALYST PHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 14888U101
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,678,999
- Percent of class
- 8.4500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-19-000736
- Form type
- SC 13G
- Filer
- CATALYST PHARMACEUTICALS, INC.
- CIK
- CIK 1369568
- Filed
- Feb 14, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership